Human papillomavirus (HPV) vaccine initiation in minority Americans.
De, P., & Budhwani, H., (2017). Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health, 144, 86-91.
Breast, colorectal and skin cancer screening practices and family history of cancer in U.S. women.
Shah, M., Zhu, K., Palmer, R.C., Jatoi, I., & Wu, H., (2007). Breast, colorectal and skin cancer screening practices and family history of cancer in U.S. women. Journal of Women’s Health, 16(4), 526-534.
The ‘Be Cancer Alert Campaign’: Protocol to evaluate a mass media campaign to raise awareness about breast and colorectal cancer in Malaysia.
Schliemann, D., Donnelly, M., Dahlui, M., Loh, S.Y., Ibrahim, N.S.B.T., Somasundaram, S., Donnelly, C., Su, T.T., (2018). The ‘Be Cancer Alert Campaign’: Protocol to evaluate a mass media campaign to raise awareness about breast and colorectal cancer in Malaysia. BMC Cancer, 18(1), 881.
African-American and Caribbean-born men’s perceptions of prostate cancer fear and facilitators for screening behaviour: A pilot study.
Cobran, E. K., Hall, J. N., & Aiken, W. D., (2018). African-American and Caribbean-born men’s perceptions of prostate cancer fear and facilitators for screening behaviour: A pilot study. Journal of Cancer Education, 33, 640-649.
Cancer screening among Korean Americans.
Sarna, L., Tae, Y.S., Kim, Y.H., Brecht, M.L., & Maxwell, A.E., (2001). Cancer screening among Korean Americans. Cancer Practice, 9(3), 134-140.
US Health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: A qualitative systematic review.
Rosen, B.L., Shepard, A., & Kahn, J.A., (2018). US Health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: A qualitative systematic review. Academic Pediatrics, 18(2S), S53-S65.
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.
Chesson, H. W., Meites, E., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E., (2018). Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States. Vaccine, 36, 4362-4368.
Barriers to treatment: describing them from a different perspective.
Devine, F., Edwards, T., & Feldman, S. R. (2018). Barriers to treatment: describing them from a different perspective. Patient Preference and Adherence, 12, 129–133.
Opportunity for catch-up HPV vaccination in young women after first delivery.
Rama, C.H., Villa, L.L., Pagliusi, S., Andreoli, M.A., Costa, M.C., Thomann, P., Alves, V.A.F., Longatto-Filho, A., & Eluf-Neto, J., (2010). Opportunity for catch-up HPV vaccination in young women after first delivery. Journal of Epidemiology and Community Health, 64(7), 610-615.
Overcoming barriers in HPV vaccination and screening programs.
Vorsters, A., Van Damme, P., Arbyn, M., Baay, M., Bosch, X., de Sanjose, S., … & Yarwood, J., (2017). Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Research, 4, 45-53.
